BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17634972)

  • 1. Sample size adaptation designs and efficiency comparison with group sequential designs.
    Cui L
    Stat Med; 2024 May; 43(11):2203-2215. PubMed ID: 38545849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulation methods to estimate design power: an overview for applied research.
    Arnold BF; Hogan DR; Colford JM; Hubbard AE
    BMC Med Res Methodol; 2011 Jun; 11():94. PubMed ID: 21689447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size determination.
    Dell RB; Holleran S; Ramakrishnan R
    ILAR J; 2002; 43(4):207-13. PubMed ID: 12391396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Fisher information matrix approximation methods in population optimal design calculations.
    Strömberg EA; Nyberg J; Hooker AC
    J Pharmacokinet Pharmacodyn; 2016 Dec; 43(6):609-619. PubMed ID: 27804003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A brief overview of pilot studies and their sample size justification.
    Kunselman AR
    Fertil Steril; 2024 Jun; 121(6):899-901. PubMed ID: 38331310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size requirements for case-control study designs.
    Edwardes MD
    BMC Med Res Methodol; 2001; 1():11. PubMed ID: 11747473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of accounting for repeated measure designs when evaluating treatment effects at multiple postoperative days.
    Huber M; Wuethrich PY
    Eur J Anaesthesiol; 2024 Jul; 41(7):539-541. PubMed ID: 38845577
    [No Abstract]   [Full Text] [Related]  

  • 8. Extension of a conditional performance score for sample size recalculation rules to the setting of binary endpoints.
    Bokelmann B; Rauch G; Meis J; Kieser M; Herrmann C
    BMC Med Res Methodol; 2024 Jan; 24(1):15. PubMed ID: 38243169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of futility boundaries for group sequential designs with two endpoints.
    Schüler S; Kieser M; Rauch G
    BMC Med Res Methodol; 2017 Aug; 17(1):119. PubMed ID: 28789615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The advantages and disadvantages of adaptive designs for clinical trials.
    Bauer P; Brannath W
    Drug Discov Today; 2004 Apr; 9(8):351-7. PubMed ID: 15081962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval.
    Liu GF; Zhu GR; Cui L
    Stat Med; 2008 Feb; 27(4):584-96. PubMed ID: 17634972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On sample size determination in multi-armed confirmatory adaptive designs.
    Wassmer G
    J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.